awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51715018-9A64ACA2-82F1-4E22-87AB-9858AFF11FDA
Q51715018-9A64ACA2-82F1-4E22-87AB-9858AFF11FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51715018-9A64ACA2-82F1-4E22-87AB-9858AFF11FDA
Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?
P2860
Q51715018-9A64ACA2-82F1-4E22-87AB-9858AFF11FDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51715018-9A64ACA2-82F1-4E22-87AB-9858AFF11FDA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a606f7373b676491b0228c490f57fb9be6b6337a
P2860
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study